Mesenchymal Stem Cells Market Outlook: Scientific Progress and Future Therapeutic Potential
Valued at USD 3.37 billion in 2024, the mesenchymal stem cells market is projected to reach USD 3.79 billion in 2025 and USD 11.26 billion by 2034, growing at a CAGR of 12.9% during the forecast period 2025–2034. North America was the largest market in 2024, while Asia Pacific is witnessing rapid growth. Participants shaping the landscape include Mesoblast, Osiris Therapeutics, Miltenyi...
0 Kommentare 0 Geteilt 4 Ansichten 0 Bewertungen